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INTRODUCTION 
Since its first description in 1802 by Bichat the buccal fat 
pad (BFP) has gained growing interest among plastic 
surgeons.1,2 It has been used for reconstructive purposes 
as early as 1977 and it has been removed with increasing 
frequency in aesthetic procedures.3,4 
Despite the multitude of clinical and aesthetic uses, the 
correct surgical indications for BFP removal have yet to 
be fully elucidated.5 Indeed, the BFP involutes with age 
and its removal may lead to an excessive thinning of the 
face that may fail to provide a more youthful appearance, 
especially considering that the use of fat grafting is 
currently one of the most common procedures for facial 
rejuvenation. On the contrary, in a chubby face the 
thinning that can be obtained might be minimal and the 
presence of masseter muscle (MM) hypertrophy should 
be ruled out. 
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Furthermore, although the procedure is widely performed 
and promoted for aesthetic purpose, few reports have 
been released and so far, literature lacks of studies 
accounting for imaging evaluation of patients undergoing 
BFP removal.  
The aim of present study is to provide an examination of 
the BFP with special emphasis on its preoperative 
evaluation in order to identify the correct indication for 
its removal and better match patients’ expectations. 
METHODS 
Between 2012 and 2016 patients seeking an improvement 
of the malar contour by reduction of the submalar 
prominence have been visited at the Department of 
Plastic Surgery of the Institution. 
Patients’ demographic data were recorded. None of the 
patients had previous history of facial trauma, surgery, 
fractures or congenital facial deformities. Patients’ 
weight was reported as stable over the previous 12 
months. A preoperative MRI was requested in order to 
correctly identify the volume of the BFP and the presence 
of a MM hypertrophy. According to clinical examination 
and the results of the preoperative imaging, patients were 
offered different treatment options. All procedures were 
performed by the same clinician. 
 
Figure 1: Intraoperative pictures of BFP removal 
through an intraoral approach; (A) A 2cm incision 
was made just approximately l cm laterally to 
Stensen's duct; (B) After blunt dissection, a moderate 
pressure was applied externally, and the fat herniated 
through the incision; (C) Picture of bilateral                    
BFP removed. 
Patients with BFP hypertrophy underwent BFP removal 
through an itraoral approach. All the surgeries were 
performed under local anaesthesia by the same operators. 
Briefly, a solution of lidocainc and epinephrine was 
injected between the first and second molar sulcus, 
retracting the cheek. A 2cm incision was made just 
approximately lcm laterally to Stensen's duct (Figure 1A). 
The buccinator was exposed and blunt dissection was 
performed to spread muscle fibers. As the fat herniated 
through the incision, its overlying sheath was penetrated, 
and a moderate pressure was applied externally, below 
the zygomatic arch (Figure 1B). The BFP was the 
clamped, electrocoagulated and excised. The opposite 
side was symmetrically operated, and the wound closed 
in layers (Figure 1C). Conversely, patients with MM 
hypertrophy received injection of 50 UI of botulinum 
toxin (BTX).6,7 
RESULTS 
Between 2012 and 2016, 8 patients (5 men and 3 women) 
requested malar contour remodelling for submalar 
hypertrophy. The patients’ ages ranged from 28 to 42 
years old (average age, 35). Patients’ body mass index 
(BMI) ranged from 19.7 to 27.5 years old (average, 23.6). 
The malar area was preoperatively analyzed with MRI 
scans in all patients. A BFP hypertrophy was identified in 
5 patients (4 men and 1 woman) (Figure 2B). The mean 
volume of the BFP in male patients was 11.2ml with a 
range of 10.3-11.9ml, while in the female patient the 
volume was 10.8 ml. Variations between the right and 
left sides were not significantly different. These five 
patients underwent the removal of the BFP with an 
intraoral approach (Figure 1). No complications have 
been observed in the postoperative period. The patients 
received broad-spectrum antibiotic therapy and oral rinse 
with diluted hydrogen peroxide. The remaining three 
patients had a MM hypertrophy (Figure 2A), for which 
they were offered BTX injections8. All patients were 
satisfied with the results.  
 
Figure 2: (A) Magnetic Resonance imaging T1-
weighted turbo spin echo sequence showing bilateral 
masseter muscle hypertrophy (white arrows); (B) 
Magnetic resonance imaging T1-weighted Turbo Spin 
Echo sequence showing bilateral buccal fat pad (BFP) 
hypertrophy (white arrows). 
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DISCUSSION 
In the early stages, surgery for fleshy midface definition 
was exclusively based on camouflaging techniques, third-
molar removal and malar augmentation with implant.5,8-9 
With the advent and growing spread of either direct or 
suction-assisted lipectomy, correction of corpulent face 
has been extensively addressed. In a selected small 
population of patients, direct intraoral BFP removal, 
alone or both with facial liposculpture and soft tissue 
lifting, is a useful tool for treating midface fullness.8-10 
Defining these cases could be somewhat challenging as a 
deep analysis of anatomical structure is fundamental. A 
clinical evaluation of the patient, based on an aesthetical 
accepted set of standards for midface contour, does not 
always allow a proper diagnosis and a consequent 
adequate treatment. Indeed, midface profile is determined 
by facial skeleton, BFP and MM mass. A full cheek face 
could underlie a hypertrophy of the BFP or a fibrous BFP 
not involuted with age, or an hypertrophy of the MM, or 
a contribution of both.5 In this condition, clinical 
evaluation may not be sufficient and imaging technique 
are needed for an accurate diagnosis. MRI is a reliable 
and consistent method for soft tissue evaluation. In the 
series, in case of a doubtful clinical examination, in order 
to better investigate the anatomical structures of the 
patients’ face, a preoperative MRI was performed, clearly 
visualizing BFP due to its pure adipose nature. Author 
were able to differentiate the anatomic border of the BFP 
in greater detail using T1 sequences in contrast to T2, 
along with the MM fibers, distinguishing BFP from MM 
hypertrophy. Anatomical studies have demonstrated that 
the BFP usually involutes with age, therefore the 
appropriateness of its removal should be carefully 
evaluated in each patient, in order to avoid developing of 
a bony cheek later in life.2 
In the series, in case of hypertrophic BFP or resistant to 
aging involution, an intraoral lipectomy was performed 
with high patients’ comfort and outcomes. Instead, in 
case of MM hypertrophy, the midface definition was 
performed with the injection of BTX, with similar results. 
According to the experience, midface contouring 
procedures should take account of both surgeons’ 
experience, patients’ expectations and anatomical 
evaluation. As such, there is no given approach suitable 
for all cases. Suggested visual criteria, clinical 
examination and imaging analysis are useful in 
establishing patient’s condition and determining the 
appropriate methods of treatment to enhance the facial 
profile.  
CONCLUSION 
In conclusion, the results obtained from BFP removal 
gives a slight improvement in face lift results. It is, 
however, important to understand that removal should be 
performed only in patients who wish to have a cheek area 
more highlighted. The technique should be used with 
caution in aesthetic patients, because thinning of the face 
is not always desirable, especially in patients with 
masseter hypertrophy and a robust BFP. On the contrary, 
given the fuller appearance of the young face, it has 
recently been suggested that lipofilling is performed to 
enhance BFP fullness during face lifting procedures.11 As 
such, the appropriateness of BFP procedures should be 
determined on a case-by-case basis, depending on the 
particular age-associated changes observed in a given 
patient. 
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